This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +22.98% per year. These returns cover a period from January 1, 1988 through April 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Microcap Article: Archive
Zacks Initiates Coverage of Wheeler Real Estate With Neutral Recommendation
by Debanjana Dey
Discover why Zacks rates Wheeler Real Estate as "Neutral", being the first on Wall Street to initiate coverage on the stock. Explore WHLR's promising growth prospects and financial health amid market challenges.
WHLRNegative Net Change
reit
Zacks Initiates Coverage of Palladyne AI With Neutral Recommendation
by Debasmita Chatterjee
Find out why Zacks has given PDYN a "Neutral" rating, being the first on Wall Street to initiate coverage on the stock. Explore how defense traction, AI innovation and strong liquidity are balanced against commercialization risks and competitive pressure.
PDYNPositive Net Change
business-services
UHT Downgraded to Neutral Amid Leasing & Rate Pressures
by Zacks Equity Research
Universal Health Realty's lease stability and dividend yield support income, but muted leasing, variable-rate debt and tenant concentration weigh on growth prospects.
UHTNegative Net Change
reit
Zacks Initiates Coverage of NERA With Neutral Recommendation
by Debasmita Chatterjee
Find out why Zacks has given NERA a "Neutral" rating, being the first on Wall Street to initiate coverage on the stock. Explore how portfolio expansion, solid rental performance, and liquidity strength are weighed against structural and regional headwinds.
NENPositive Net Change
finance
Zacks Initiates Coverage of CBL With Neutral Recommendation
by Debanjana Dey
Discover why Zacks rates CBL & Associates as "Neutral", being the first on Wall Street to initiate coverage on the stock. Explore CBL's leasing momentum and financial health amid market challenges.
CBLNegative Net Change
reit
Zacks May View on Equity Markets
by John Blank
Recent trade policy announcements have raised economic uncertainty, pushed up market volatility, and tightened financial conditions.
asset-allocation
International: Update on Global Regions
by John Blank
"For companies that generate more than 50% of sales inside the U.S., the blended earnings growth rate is 14.4%. For companies that generate more than 50% of sales outside the U.S., the blended earnings growth rate is 20.8%."
asset-allocation
May Sell-Side and Buy-Side Consensus at a Glance
by John Blank
FactSet "Bottoms-up" consensus, going 12 months out? This outside consensus was for 6,578. That latest consensus was (+19.9%) above a closing price 5,485
asset-allocation
May Asset Allocation Guidelines
by John Blank
Five different frameworks specify portfolio risk tolerance: from Risky "Max Growth" to Conservative "Income." Choose one that fits you.
asset-allocation
ZRS Chart of the Month
by John Blank
Data showed investors across the board upgrades. Zacks Industry Ranks supplied one Very Attractive Sector: Financials.
asset-allocation
Zacks Initiates Coverage of Park With Neutral Recommendation
by Debasmita Chatterjee
Discover why Zacks has issued a "Neutral" rating for Park, being the first on Wall Street to initiate coverage on the stock. Explore its solid balance sheet, aerospace exposure, and dividend history, weighed against margin pressure and supply chain risks.
PKENegative Net Change
aerospace
Autoscope Earns Outperform Rating on Yield, Growth & Valuation Upside
by Zacks Equity Research
Autoscope has been upgraded to "Outperform" on 7% yield, federal tailwinds, high-margin product growth, strong cash flow and deep valuation discount at 6X EBITDA, with $7 million in liquidity.
AATCNegative Net Change
business-services
Zacks Initiates Coverage of Summit Midstream With Neutral Recommendation
by Urbashi Dutta
Discover why Zacks, being the first on Wall Street to initiate the stock coverage, rates SMC as "Neutral." Explore SMC's improved liquidity, growth moves and asset strength, balanced by integration risks and customer concentration.
SMCPositive Net Change
energy oil-energy
Zacks Initiates Coverage of BayFirst With Outperform Recommendation
by Debasmita Chatterjee
Find out why Zacks has given BayFirst an "Outperform" rating, being the first on Wall Street to initiate coverage on the stock. Explore how tech innovation, regional growth and strong earnings tailwinds position it as a standout in community banking.
BAFNNegative Net Change
finance
Zacks Initiates Coverage of Ohio Valley Banc With Outperform Recommendation
by Debanjana Dey
Discover why Zacks rates Ohio Valley Banc as "Outperform", being the first on Wall Street to initiate coverage on the stock. Explore OVBC's disciplined cost actions, financial health and operational efficiency.
OVBCNegative Net Change
banking finance
Zacks Initiates Coverage of Old Point With Neutral Recommendation
by Debasmita Chatterjee
Discover why Zacks has issued a "Neutral" rating for Old Point, being the first on Wall Street to initiate coverage on the stock. Explore its record earnings, margin gains and regional strength, balanced against shrinking loans and rising credit risks.
OPOFNegative Net Change
finance
AXIL Brands Stock Price Decreases 2.2% as Earnings Decline Y/Y in Q3
by Zacks Equity Research
AXIL's Q3 earnings falls despite higher revenues. Stock slumps 37% in a month as investors weigh growth plans, cost pressures and outlook.
AXILNegative Net Change
consumer-staples earnings
Oil-Dri Earns Outperform Rating on Renewable Diesel, Ultra Pet Wins
by Zacks Equity Research
ODC gains an "Outperform" rating as renewable diesel demand soars, and the Ultra Pet acquisition boosts growth, profitability and market presence.
ODCNegative Net Change
basic-materials
2 More Defensive Small Caps
by Mark Zinski
Diverse end markets can prove advantageous during economic uncertainty.
SPLPPositive Net Change ODCNegative Net Change
industrial-products rating-upgrade small-cap
NVFY Stock Slides Post Earnings Despite Narrower Net Loss
by Zacks Equity Research
Nova LifeStyle reports lower revenues but improved margins in 2024, with sales gains in North America offset by declines in Asia and other regions.
NVFYNegative Net Change
consumer-discretionary earnings
BIAF Stock Surges Post Improved Earnings and Record 2024 Revenues
by Zacks Equity Research
bioAffinity witnesses record 2024 revenues, driven by CyPath Lung adoption, Medicare coverage and strategic expansion across healthcare networks.
BIAFNegative Net Change
biotechnology biotechs earnings medical
Blue Dolphin Posts 2024 Loss Amid Margin & Liquidity Pressures
by Zacks Equity Research
BDCO swings to a loss in 2024 as weak margins, lower sales and rising impairments weigh on results. Liquidity and working capital also decline.
BDCONegative Net Change
earnings energy oil-energy
VASO Stock Rises Post Q4 Revenue Growth and Solid Segment Gains
by Zacks Equity Research
Vaso's fourth-quarter 2024 results reflect record revenue and strong segment growth despite a decline in full-year profit due to higher operating expenses.
VASOPositive Net Change
earnings medical medical-devices
Zacks April View on Equity Markets
by John Blank
In the prior 10 instances, of the S&P500 falling -10% from a record high in 20 days or fewer, we have a nice record to mine for insights.
asset-allocation
ZRS Chart of the Month
by John Blank
Info Tech remains overpriced, at extreme valuations, still +37% over the median. That is the remaining AI "froth factor." Factor in high tech mega-cap P/E multiples too.
asset-allocation